Recent summary of changes to the LAM
The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.
Additions
| Busulfan
injection 60mg/10mL, vial |
| Dalbavancin injection 500mg, vial (SAS) |
| Electrolyte replacement oral (containing sodium chloride, sodium
acid citrate, potassium chloride, glucose) O.R.S. powder for oral liquid, 4.9
g sachet |
| Isotretinoin capsule 5mg, 30mg, 40mg |
| Mogamulizumab injection 20 mg/5 mL |
| Phytomenadione tablet 10mg (SAS) |
| Risdiplam tablet 5mg |
| Zilucoplan injection 16.6 mg/0.416 mL, 23 mg/0.574 mL, 32.4
mg/0.81 mL |
Amendments
| Clarithromycin
tablet 250mg |
| Colecalciferol capsule 1.25mg (50,000 units) |
| Isotretinoin capsule 10mg, 20mg |
| Nicotine oral spray 1 mg/actuation |
| Rifaximin tablet 550mg |
Deletions
| Aqueous
cream with Coal Tar Solution 3% |
| Cetomacrogol cream with clioquinol 1% 100g |
| Electrolyte replacement oral (containing sodium chloride, potassium chloride, sodium citrate, citric acid, sucrose, glucose) Gluco-lyte® powder for oral liquid, 40g sachet |
| Ketoprofen SR capsules 100mg, 200mg |
| Nicotine inhalation 15 mg |
| Phytomenadione capsule 10mg |
